Effective September 1, 2020, CPL will implement modifications to our Critical and Alert thresholds for therapeutic drug and toxicology monitoring.
These improvements underwent an extensive internal review and are driven by guidance from literature, instructions from test manufacturers and a selected survey of laboratories. As always, CPL works to establish critical and alert analytes and thresholds as a foundation for our client base, balancing the notification of a potential threat to patients against oversaturation of client alert notifications. We encourage all clients to critically review our Critical and Alert policy, analytes, and thresholds, to determine if they are suitable for your patient population or require customization. Please contact your CPL Account Representative for more information.